Sandoz unveils plan for biosimilar expansion and new $300M factory in Slovenia

LONDON — Sandoz is betting big on its newly formed biosimilar unit, as it reveals plans to grow its pipeline there by more than sevenfold and also invests $300 million in a new biosimilar manufacturing site. ...